MedPath

Novel Amblyopia Treatment With Virtual Reality Games

Not Applicable
Recruiting
Conditions
Amblyopia
Interventions
Device: Optical Correction
Device: Therapeutic Dichoptic Virtual Reality Games
Registration Number
NCT06049459
Lead Sponsor
Marjean Kulp
Brief Summary

The goal of this study is to compare the change in amblyopic eye acuity between treatment periods in children with amblyopia, aged 5-17 years. The main question it aims to answer is:

Is a 16-week course of amblyopia treatment using Vivid Vision Therapeutic (Dichoptic) Virtual Reality Games for approx. 25 min/day, 6 days/week more effective for improvement in amblyopic-eye VA, binocularity (stereoacuity, suppression, alignment), contrast sensitivity, attention, oculomotor function, visual-motor integration, and quality of life than 16 weeks of continued glasses alone?

Participants will each serve as their own control and complete:

Treatment period 1: Continued optical correction (glasses) alone for 16 weeks; Treatment period 2: Vivid Vision Therapeutic (Dichoptic) Virtual Reality Games for 16 weeks (approx. 25min/day, 6 days/week) plus continued optical correction

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
8
Inclusion Criteria

Patients ages 5 to 17 years of age

  • Moderate to severe unilateral amblyopia (logMAR best corrected visual acuity 0.3 to 1.3) associated with anisometropia and/or strabismus of ≤5pd
  • Age normal VA in the nonamblyopic eye
  • Spectacle correction (if required) worn for at least 16 weeks, or until stability of VA is demonstrated (<0.1 logMAR change by the same testing method measured on 2 exams at least 8 weeks apart)
  • Interocular difference of ≥ 3 lines
  • No amblyopia treatment in the past 2 weeks
  • An interpupillary distance of 52-72 mm (inclusive)
Exclusion Criteria
  • Myopia greater than -6.00 diopters (D) spherical equivalent in either eye.
  • Previous intraocular or refractive surgery.
  • Previous dichoptic treatment > 2 weeks in duration
  • Ocular co-morbidity that may reduce visual acuity determined by an ocular examination performed within the past 7 months (Note: nystagmus per se does not exclude the participant if the above visual acuity criteria are met).
  • Diplopia more than once per week over the last week prior to enrollment by parental report.
  • Down syndrome or cerebral palsy.
  • Light-induced seizures
  • Known simulator sickness
  • Severe developmental delay that would interfere with treatment or evaluation (in the opinion of the investigator). Participants with mild speech delay or reading and/or learning disabilities are not excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Optical Correction aloneOptical CorrectionOptical correction alone (16 weeks) (Each participant will complete both study conditions.)
Therapeutic (Dichoptic) Virtual Reality Games plus Continued Optical CorrectionOptical CorrectionTherapeutic (Dichoptic) Virtual Reality Games plus continued optical correction (16 weeks) (Each participant will complete both study conditions.)
Therapeutic (Dichoptic) Virtual Reality Games plus Continued Optical CorrectionTherapeutic Dichoptic Virtual Reality GamesTherapeutic (Dichoptic) Virtual Reality Games plus continued optical correction (16 weeks) (Each participant will complete both study conditions.)
Primary Outcome Measures
NameTimeMethod
Difference in Mean Change in Amblyopic Eye Visual AcuityBaseline to 16 weeks versus 16 weeks to 32 weeks

Optical correction worn for testing using Amblyopia Treatment Study (ATS) protocol; HOTV for ages 5-6 years; E-ETDRS for ages 7 years and older

Secondary Outcome Measures
NameTimeMethod
Difference in Mean Change in Amblyopic-Eye Contrast SensitivityBaseline to 16 weeks versus 16 weeks to 32 weeks

Optical correction worn for testing. Spot Checks;Contrast sensitivity scores range from unable (\<0.90), and then from 0.90 to 2.05 (by 0.05 log contrast sensitivity units).

Difference in Change in Stereoacuity/BinocularityBaseline to 16 weeks versus 16 weeks to 32 weeks

Optical correction worn for testing. Stereoacuity scores (seconds of arc) calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) tests. Lower scores indicate better stereoacuity. Nil (4000) defined as an incorrect response (or lack of an attempt) on the butterfly without a correct response on 800 seconds of arc level of Randot Preschool stereoacuity test. Stereoacuity scores will be ordered and assigned a rank score. Change in stereoacuity will be calculated as the difference in change in ranked score.

Difference in Mean Change in reading eye movementsBaseline to 16 weeks versus 16 weeks to 32 weeks

Optical correction worn for testing with Readalyzer eye tracker.

Difference in Mean Change in AttentionBaseline to 16 weeks versus 16 weeks to 32 weeks

Optical correction worn for testing. The Children's Color Trails Test (CCTT) is a neuropsychological standardized test that measures attention, divided attention, and speed of mental processing.

Difference in Mean Change in Pediatric Eye Questionnaire (PedEyeQ)Baseline to 16 weeks versus 16 weeks to 32 weeks

Pediatric Eye Questionnaire (PedEyeQ) domain score; scores for questionnaire items will be obtained from published look-up tables available at www.pedig.net; scaled to score from 0 to 100 (worst to best)

Difference in Mean Change in visual-motor integrationBaseline to 16 weeks versus 16 weeks to 32 weeks

Optical correction worn for testing. Beery Visual-Motor Integration; standard scores with mean of 100, standard deviation of 15

Trial Locations

Locations (1)

The Ohio State University College of Optometry

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath